These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2579055

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sulphydryl-mediated DNA breakage by phlemomycin in Escherichia coli.
    Sleigh MJ, Grigg GW.
    Mutat Res; 1977 Feb; 42(2):181-90. PubMed ID: 320461
    [Abstract] [Full Text] [Related]

  • 24. Phleomycin resistance as a dominant selectable marker in CHO cells.
    Mulsant P, Gatignol A, Dalens M, Tiraby G.
    Somat Cell Mol Genet; 1988 May; 14(3):243-52. PubMed ID: 2453083
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phleomycin-induced DNA lesions and their repair in Escherichia coli K12.
    Nakayama H.
    Basic Life Sci; 1975 May; 5B():483-85. PubMed ID: 1103864
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. NMR study of the effects of some bleomycin C-termini on the structure of a DNA hairpin with the 5'-GC-3' binding site.
    Lehmann TE, Murray SA, Ingersoll AD, Reilly TM, Follett SE, Macartney KE, Harpster MH.
    J Biol Inorg Chem; 2017 Jan; 22(1):121-136. PubMed ID: 27858165
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Studies on the total synthesis of tallysomycin. Synthesis of the threonylbithiazole moiety containing a structurally unique glycosylcarbinolamide.
    Sznaidman ML, Hecht SM.
    Org Lett; 2001 Sep 06; 3(18):2811-4. PubMed ID: 11529763
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Phleomycin and bleomycin: molecular model building studies.
    Pietsch P.
    Cytobios; 1978 Sep 06; 23(91-92):187-98. PubMed ID: 90586
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Structure and action of bleomycin.
    Umezawa H.
    Prog Biochem Pharmacol; 1976 Sep 06; 11():18-27. PubMed ID: 63962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.